CSPC Pharmaceutical Group Limited (CSPCY) Financials
CSPCY Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| Dec. 31, 2025 | 6.7 billion | 1.7 billion |
| Sept. 30, 2025 | ? | ? |
| June 30, 2025 | 6.4 billion | 1.6 billion |
| March 31, 2025 | ? | ? |
CSPCY Free Cash Flow and Stock based compensation
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| Dec. 31, 2025 | 284.4 million | ? |
| Sept. 30, 2025 | ? | ? |
| June 30, 2025 | 37.0 million | -10.1 million |
| March 31, 2025 | ? | ? |
CSPCY Net Income
| Date | Net Income |
|---|---|
| Dec. 31, 2025 | 187.1 million |
| Sept. 30, 2025 | 148.2 million |
| June 30, 2025 | 355.8 million |
| March 31, 2025 | 222.0 million |
CSPCY Cash and Debt
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| Dec. 31, 2025 | 1.3 billion | - | 25.8 million |
| Sept. 30, 2025 | - | - | - |
| June 30, 2025 | 1.4 billion | - | 34.6 million |
| March 31, 2025 | - | - | - |
CSPCY Shares Outstanding
CSPCY Expenses
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| Dec. 31, 2025 | 109.2 million | 438.4 million | 535.8 million | - |
| Sept. 30, 2025 | - | - | - | - |
| June 30, 2025 | 21.1 million | 374.7 million | 482.0 million | 425.8 million |
| March 31, 2025 | - | - | - | - |
CSPCY Cost of Revenue
| Date | Revenue | Cost of Revenue |
|---|---|---|
| Dec. 31, 2025 | 1.8 billion | 614.9 million |
| Sept. 30, 2025 | - | - |
| June 30, 2025 | 233.2 million | 637.3 million |
| March 31, 2025 | - | - |
CSPCY
Price: $4.14
Dividend Yield: 3.87%
Forward Dividend Yield: 3.04%
Payout Ratio: 51.13%
Dividend Per Share: 0.12 USD
Earnings Per Share: 0.20 USD
P/E Ratio: 19.45
Exchange: PNK
Sector: Healthcare
Industry: Drug Manufacturers - General
Country: China
Market Capitalization: 11.1 billion
Average Dividend Frequency: 2
Years Paying Dividends: 8
DGR3: 14.41%
DGR5: 11.64%